학술논문
Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic–Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies.
Document Type
Article
Source
European Journal of Drug Metabolism & Pharmacokinetics; Nov2022, Vol. 47 Issue 6, p789-802, 14p
Subject
Language
ISSN
03787966
Abstract
Copyright of European Journal of Drug Metabolism & Pharmacokinetics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)